Plus: More Americans filed for initial jobless benefits last week. The FDA says Eli Lilly has resolved the shortage of its Tirzepatide diabetes and weight-loss drug. J.R. Whalen reports.\n\n\n\nSign up for the WSJ's free What's News newsletter.\xa0\n\nLearn more about your ad choices. Visit megaphone.fm/adchoices